Arno Therapeutics, Inc — key financial figures for fiscal year 2015 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2015)

-$11.5M

Total Assets (FY2015)

$361.2K

Total Equity (FY2015)

-$8.6M

Cash Flows from Operating Activities (FY2015)

-$10.0M

Source: Arno Therapeutics, Inc 10-K filing (FY2015). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.